0001140361-12-040626.txt : 20120917
0001140361-12-040626.hdr.sgml : 20120917
20120917141118
ACCESSION NUMBER: 0001140361-12-040626
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120913
FILED AS OF DATE: 20120917
DATE AS OF CHANGE: 20120917
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: AYERS JONATHAN W
CENTRAL INDEX KEY: 0001184149
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19271
FILM NUMBER: 121094681
MAIL ADDRESS:
STREET 1: IDEXX LABORATORIES, INC.
STREET 2: ONE IDEXX DRIVE
CITY: WESTBROOK
STATE: ME
ZIP: 04092
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IDEXX LABORATORIES INC /DE
CENTRAL INDEX KEY: 0000874716
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 010393723
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE IDEXX DRIVE
CITY: WESTBROOK
STATE: ME
ZIP: 04092-2041
BUSINESS PHONE: 2075560300
MAIL ADDRESS:
STREET 1: ONE IDEXX DRIVE
CITY: WESTBROOK
STATE: ME
ZIP: 04092-2041
FORMER COMPANY:
FORMER CONFORMED NAME: IDEXX CORP / DE
DATE OF NAME CHANGE: 19600201
4
1
doc1.xml
FORM 4
X0306
4
2012-09-13
0
0000874716
IDEXX LABORATORIES INC /DE
IDXX
0001184149
AYERS JONATHAN W
ONE IDEXX DRIVE
WESTBROOK
ME
04092
1
1
0
0
Chairman, President & CEO
Common Stock
2012-09-13
4
M
0
20000
17.135
A
366686
D
Common Stock
2012-09-13
4
S
0
15000
99.2531
D
351686
D
Non-Qualified Stock Options (right to buy)
17.135
2012-09-13
4
M
0
20000
0
D
2013-02-06
Common Stock
20000
84164
D
The sale reported above was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 04/27/2012.
The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $98.64 to $99.64, inclusive. The reporting person hereby undertakes to provide upon request to SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.
Grant of options to buy shares of common stock becomes exercisable as to 30,000 shares on 02/06/2004, 02/06/2005, 02/06/2006, 02/06/2007, and the remaining 24,164 shares on 02/06/2008.
Jennifer L. Panciocco, Attorney-in-Fact for Jonanthan W. Ayers
2012-09-17